wcn2017 webbanner 1200x168

wcn 2017 logo

WCN2017AbstractBanner

wcn2017 webbanner 1200x168

Abstracts

 

ABSTRACT SUBMISSION IS NOW CLOSED

 

LDI Poster Printing Service 

The World Congress of Nephrology 2017 has selected Call4PostersTM as their preferred poster printing service for WCN 2017.
This service is the simple and most convenient way to print your poster and have it delivered at the congress in Mexico City for onsite pick up.
Additional information about this service including the link to start submitting posters for printing will be send to presenting abstract authors Mid-February by email.
Please take note there will be no onsite poster printing service.
For any queries about the Call4PostersTM printing, please contact societyposter@learnersdigest.com

 

Moderated Poster Sessions

Moderated poster sessions will be held in the Exhibition Hall on the following days:
Saturday, 22 April 12:00-13:15
Sunday, 23 April   12:00-13:15
Monday, 24 April  12:00-13:15

Further details will be available in the online searchable program as of mid February. For online searchable program please click here https://www.wcn2017.org/program/program-at-a-glance.

 

Instructions for submitting your abstracts:

 

SUBMISSION OF ABSTRACTS 

Abstracts should concern all aspects of nephrology, the treatment of renal disease or the scientific background to the study of the kidney.

 

MAILING OR FAXING YOUR ABSTRACT 

A hard copy of the submitted abstract is NOT required for submission. All submissions must be made through the ISN WCN 2017 website.

  

CONFIRMATION 

You will receive an email within two (2) business days of submitting your abstract. If you submit on the date of the deadline and do not receive confirmation within 48 hours, please contact Shira Strachova at ISN via sstrachova@theisn.org.

 

NOTIFICATION 

The Presenting Author of each abstract accepted for publication/presentation at the Congress will be notified by January 4, 2017. Abstract submitters are entitled to register at the discounted registration fees provided they register by the early bird deadline ( January 23, 2017).

If the Presenting Author is unable to present the abstract, another Co-Author can take his/her place as long as he/she is duly registered to the Congress. A letter from the Presenting Author informing about the change is requested and must be sent to the Congress Secretariat by no later than January 31, 2017. This letter must also include the registration number of the new presenting author.

 

WITHDRAWAL/CHANGES 

Submitted abstracts CANNOT be withdrawn or changed. No exceptions will be made.

 

ORIGINAL ABSTRACTS 

Submitted abstracts must describe unpublished work which is not already in press and which is not awaiting possible acceptance by any other society/event that publishes its proceedings.

 

ABSTRACT PUBLICATION 

Accepted abstracts will be published electronically in the searchable databases on the WCN 2017 and ISN websites. No printed Abstract Book will be produced. 

CONGRESS REGISTRATION BY JANUARY 31, 2017 IS MANDATORY in order to be published as described above and for the Poster/Oral presentation. If the Presenting Author is unable to present the abstract, another Co-Author can take his/her place as long as he/she is duly registered to the Congress. A letter from the Presenting Author informing about the change is requested and must be sent to the Congress Secretariat by no later than January 31, 2017. If Selected Abstract presenters fail to register by January 31, 2017, no abstract will be published nor the Poster/Oral presentation be presented at the Congress.

 

COPYRIGHT 

By submitting this abstract, the author assigns copyright to the ISN.

 

ORGAN TRAFFICKING AND TOURISM ETHICS COMPLIANCE 

ISN supports the need to stop practices and policies of organ trafficking and tourism. Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the below policy documents. To be eligible to submit an abstract for the ISN WCN 2017, submitters must disclose that the author(s)/ scientist(s) have not violated any aspect of the following:

The Declaration of Istanbul on Organ Trafficking and Transplant Tourism Lancet. 2008 Jul 5;372 (9632):5-6.

For Live Kidney Donation - The Consensus Statement of the Amsterdam Forum (Transplantation 79(6): S53-S66, 2005).

For Live Donation of Extrarenal Organs - The Consensus Statement of the Vancouver Forum (Transplantation 81(4): 1373-1385, 2006).

For Studies of Xenotransplantation - The International Xenotransplantation Association Ethics Committee Position Paper on The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003).

For research involving human subjects - The Helsinki Declaration of The World Medical Association.

The Ethical Statements of the Transplantation Society, TTS Ethics Policy.

The TTS Ethics China.

The Ethical Statements of the International Xenotransplantation Association.

 

CATEGORIES AND TOPICS 

Abstracts will be considered for Moderated Poster Presentation or Oral Presentation (only limited slots are available for oral presentation during WCN 2017).

Abstract categories:

1. Diabetes and Diabetic Kidney Disease
Diabetic Nephropathy – Experimental Models
Diabetes Mellitus (Clinical)
Hypertension - Clinical and Experimental Models, Renal Haemodynamics and Vascular Physiology
Diabetic Nephropathy – Biomarkers of Disease
Genetics of Kidney Disease –Diabetic Kidney Disease


2. Translational and Clinical Nephrology
Cystic Disease: Genetics and Cell Biology, Models, and Experimental Therapies
GN – Experimental Models
Renal Pathology, Experimental Pathology, incl. Immune and Inflammatory Mechanisms
Other Renal Disease - Experimental Models
Primary Glomerular Disease (Clinical)
Secondary Glomerular Disease
Vasculitides (Clinical)
Tubulointerstitial Renal Disease, Stones and Urinary Infection
Paediatric Nephrology
ADPKD—Update on Diagnosis, Monitoring Progression and Treatment
Pregnancy and CKD
Supportive Care, including End-of-Life Issues
Clinical Nephrology - General Aspects
Autoimmune Disorders and Kidney Disease
Infection and Renal Disease
HIV – Nephropathy and Other Associated Kidney Lesions


3. Acute Kidney Injury (AKI)
Acute Kidney Injury– Experimental Models
Clinical Studies including Toxic Nephropathy
Biomarkers for Acute Kidney Injury
Acute Renal Failure – Clinical
Acute Kidney Injury - Onco-Nephrology (Diseases)
Acute Kidney Injury – Onco-Nephrology (Drugs)
Acute Kidney Injury – Pregnancy (Pre-Eclampsia, TMA, HELLP, Other Causes)
Acute Kidney Injury – Update On CRRT, SLED, etc
Extracorporeal Therapies - Intoxications, Overdoses, Liver Failure, etc

4. Chronic Kidney Disease (CKD)
Acid Base and Electrolyte Abnormalities,
Cardiovascular Complications of CKD 3-5
Chronic Kidney Disease Diagnosis, Classification and Progression
Epidemiology, Outcomes and Health Service Research In CKD
Bone and Mineral Metabolism
Anaemia (CKD 3-5)
Nutrition (CKD 3-5)
Infection (CKD 3-5)
Chronic Kidney Disease – Mesoamerican Nephropathy
Chronic Kidney Disease – Diseases and Drugs

5. Dialysis and Transplantation
Extracorporeal Dialysis: Techniques and Adequacy
Peritoneal Dialysis
Vascular Access in Dialysis
Haemodialysis
Complications of Dialysis
Epidemiology, Outcomes and Health Services Research in Dialysis
Transplantation: Basic Science and Immune Tolerance
Clinical Studies in Renal Transplantation
Cardiovascular Complications Of CKD 5D
Bone and Mineral Metabolism (CKD 5D)
Anaemia (CKD 5D)
Nutrition (CKD 5D)
Infection (CKD 5D)
Conservative Management of Advanced CKD (Vs. Dialysis)
Palliative Care for CKD/ESRD
Quality Of Life in Dialysis

6. Basic Science
Tubular Functions: Electrolytes, Minerals and Acid-Base
Cell Signaling, Cell Growth Control, Hormones and Cytokines
Renal Development and Stem Cells
Inherited Diseases and Molecular Genetics
Podocytes and Glomerular Function

FURTHER INSTRUCTIONS FOR COMPLETING YOUR ONLINE ABSTRACT SUBMISSION 

Please check your abstract carefully for typographical errors, misspellings, poor hyphenation, etc. They will be glaringly apparent in the published abstract.

You are allowed to use 3400 characters. This count includes characters and spaces in the following: Abstract Title, Abstract Body, Authors/Institutions, Table, and Figures.

Click the buttons on the left side of the abstract submissions screen and complete each section by following the instructions within each section. Please note, the sections of the menu which are followed by an asterisk (*) must be filled out in order for your abstract to be submitted successfully. The required sections are:

  • Authors and Institutions
  • Correspondence Information
  • Category
  • Questionnaire
  • Transparency Declaration Ethics Statement
  • Keywords
  • Abstract Title
  • Abstract Body
  • Submit Abstract

 

CATEGORY 

Choose only one (1) Category.

 

TITLE 

Type in CAPITAL LETTERS. Lowercase may be used for abbreviations only, for example, mRNA. If you use abbreviations, please spell them out.

 

AUTHORS 

Type in lower case.

 

PRESENTING AUTHOR 

The Presenting Author must also be the Contact Author and all WCN 2017 abstract follow-up communications will be sent to the Presenting Author.

 

AFFILIATION 

Type in lower case. Type name and institution, city and country only.

 

BODY OF ABSTRACT 

State the purpose of the study, describe the method, summarize the results presenting sufficient details to support the conclusions, and give the conclusions reached (it is not acceptable to state "The results will be discussed"). Divide the text into no more than 3-4 paragraphs. Use numerals for numbers and only very well-known abbreviations e.g. ml, Osm, GFR. If you must use other abbreviations, please explain them the first time they appear. Limit the use of symbols (i.e. use M or F to indicate Male and Female instead of the symbol font). Do not identify yourself or your institution in the text.

 

TABLES AND GRAPHS 

Simple tables and graphs may be included if they fit within the size constraints of the online program.